
China Jo-Jo Drugstores, Inc. Balance Sheet 2020-2011 | CJJD
Brief overview of China Jo-Jo Drugstores, Inc.'s financial position
The balance sheet is assessed across five available annual reports spanning 2016 to 2020.
Assets advanced +60.3% to $99.5 million from $62.1 million; annual growth near 12.5% reflects a fast increase in scale.
Liabilities grew faster than assets: +88.8% versus +60.3%. A substantial part of expansion was externally funded.
Cash exceeds interest-bearing debt, producing net debt of -$8.4 million. The balance sheet therefore carries a net cash position.
Retained earnings are negative at -$36.4 million. This reduces the formal capital cushion, although large shareholder returns may have contributed.
Overall picture
China Jo-Jo Drugstores, Inc. retains a reasonably healthy balance sheet structure, which still needs support from earnings and cash flow.
Annual Balance Sheet China Jo-Jo Drugstores, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-8.36 M | 16.6 M | 4.05 M | -5.67 M | 11 M | 11.8 M | 3.83 M | 2.66 M | 376 K | -3.79 M |
Long Term Debt |
4.12 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
23.3 M | 547 K | 139 K | 496 K | 636 K | 315 K | 279 K | 15.6 K | 34.4 K | 153 K |
Total Current Liabilities |
57.4 M | 55.2 M | 54.8 M | 40 M | 42.1 M | 42 M | 31.3 M | 29.7 M | 22.6 M | 11.7 M |
Total Liabilities |
80.7 M | 55.8 M | 55 M | 40.5 M | 42.8 M | 42.3 M | 31.5 M | 29.7 M | 22.6 M | 11.9 M |
Deferred Revenue |
708 K | 772 K | 4.04 M | 2.68 M | 2.61 M | 3.76 M | 3.19 M | 4.83 M | - | - |
Retained Earnings |
-36.4 M | -30.6 M | -29.7 M | -12.6 M | -6.96 M | -7.4 M | -8.26 M | 17.1 M | 32.7 M | 24.6 M |
Total Assets |
99.5 M | 72.7 M | 73.8 M | 67.2 M | 62.1 M | 59.5 M | 45.9 M | 67.8 M | 75 M | 53.9 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of China Jo-Jo Drugstores, Inc., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Pharmaceutical retailers
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
BOQI International Medical
BIMI
|
- | 6.33 % | $ 5.86 M | ||
|
Аптеки 36.6
APTK
|
- | - | - | ||
|
Trxade Group
MEDS
|
- | 4.55 % | $ 5.8 M | ||
|
111
YI
|
$ 3.56 | -9.87 % | $ 620 M | ||
|
Rite Aid Corporation
RAD
|
- | - | $ 35.5 M | ||
|
Walgreens Boots Alliance
WBA
|
- | - | $ 10.3 B | ||
|
PetMed Express
PETS
|
$ 1.98 | -1.49 % | $ 41.4 M | ||
|
LifeMD
LFMD
|
$ 3.64 | -5.21 % | $ 164 M | ||
|
Greenlane Holdings
GNLN
|
$ 1.68 | -6.14 % | $ 12.6 M |